Thomas DesRosier, Senior VP, General Counsel at GENZYME CORP (GENZ), sold 1,972 shares at $45.60 ($90K) on 2010-05-25, disclosed to the SEC on 2010-05-26.
Open-market sale of $90k GENZ by Senior VP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MCRB | SELL | 2026-02-18 | $661 | — | Filing → |
| MCRB | SELL | 2025-11-18 | $1K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $1K | — | Filing → |